Introduction
IMPA2, a member of the inositol monophosphatase family, catalyzes the dephosphorylation of inositol monophosphate, playing a crucial role in phosphatidylinositol signaling. This enzyme utilizes various substrates, including myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP. IMPA2 serves as a pharmacological target for lithium (Li+) action in the brain and is believed to be involved in schizophrenia and bipolar disorder.
Description
Recombinant human IMPA2, fused with a 20 amino acid His tag at the N-terminus, is produced in E. coli. This single, non-glycosylated polypeptide chain comprises 308 amino acids (residues 1-288) and has a molecular weight of 33.5 kDa. Purification of IMPA2 is achieved through proprietary chromatographic techniques.
Physical Appearance
Sterile, colorless solution.
Formulation
The IMPA2 solution (0.25 mg/ml) is supplied in 20mM Tris-HCl buffer (pH 8.0), containing 10% glycerol and 2mM DTT.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 95.0% as determined by SDS-PAGE analysis.
Synonyms
Inositol monophosphatase 2, IMP 2, IMPase 2, Inositol-1(or 4)-monophosphatase 2, Myo-inositol monophosphatase A2, IMPA2, IMP.18P.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MKPSGEDQAA LAAGPWEECF QAAVQLALRA GQIIRKALTE EKRVSTKTSA ADLVTETDHL VEDLIISELR ERFPSHRFIA EEAAASGAKC VLTHSPTWII DPIDGTCNFV HRFPTVAVSI GFAVRQELEF GVIYHCTEER LYTGRRGRGA FCNGQRLRVS GETDLSKALV LTEIGPKRDP ATLKLFLSNM ERLLHAKAHG VRVIGSSTLA LCHLASGAAD AYYQFGLHCW DLAAATVIIR EAGGIVIDTS GGPLDLMACR VVAASTREMA MLIAQALQTI NYGRDDEK.